Kent Axcell, BS1• Yesul Kim, MD2• Edward J. Fox, MD3• Joseph J. Drabick, MD4• Bryan E. Anderson, MD2
Kent Axcell, BS1• Yesul Kim, MD2• Edward J. Fox, MD3• Joseph J. Drabick, MD4• Bryan E. ...
A 60-year-old man presented to the emergency room with a left upper extremity angiosarcoma secondary to chronic lymphedema of the left upper extremity.
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
While most cases of chronic lymphocytic leukemia are appropriately managed with medication therapy, rare cases require the use of additional treatment modalities. Which of these other treatments have you...
The survival outcomes for patients diagnosed with this chronic lymphocytic leukemia complication have remained poor for decades. Can you name the complication? Take the quiz to find out!
Acute myeloid leukemia is one of the most common types of leukemia in adults, but what is the incidence of this type of leukemia among overall cases of cancer? Find out with this pop quiz.
Blood eosinophil count is becoming increasingly recognized by the respiratory specialist community as a clinically relevant biomarker to help estimate affective management strategies, but the use is still...
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
In this episode, Amit Correa, MD, discusses the clinical evaluation and management of patients with an oral ulcer, including the causes, management of a patient with an aphthous ulcer, malignant and...
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
In this podcast, Nirmish Shah, MD, discusses an overview, the results, and the preclinical and clinical impact of the study titled Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to...
